Business Context and Reporting Period
Pavmed Inc. (PAVM), an emerging growth company incorporated in Delaware, filed this Form 8-K on December 22, 2020. The report details the closing of a previously announced equity offering.
Key Financial Metrics
This filing reports on a specific capital raising event rather than periodic financial performance. The filing text does not provide clear values for revenue, profit, cash flow, margins, or existing debt levels.
- Shares Sold: 5,062,500 shares of common stock.
- Offering Price: $1.60 per share.
- Placement Agents: Maxim Group LLC (lead) and Lake Street Capital Markets LLC (co-placement agent).
- Registration: Conducted under an existing shelf registration statement (Form S-3, No. 333-248709).
Material Changes
The primary material change is the increase in outstanding common stock and the influx of capital resulting from the closing of the offering on December 22, 2020. No other material changes to operations or financial position are detailed in this specific document.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosures associated with the equity offering. The press release regarding the closing is attached as Exhibit 99.1 but its specific content is not included in the provided text.
Investor Verification Checklist
- Verify the total gross proceeds from the offering (5,062,500 shares x $1.60).
- Review the attached press release (Exhibit 99.1) for the intended use of proceeds.
- Confirm the updated number of outstanding shares and potential dilution impact.
- Check the company's latest 10-K or 10-Q for current liquidity and debt positions, as this 8-K does not provide them.